Search clinical trials for: TIVA

Total 371 results

University Hospital, Geneva

Suspended

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Stage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin Melanoma

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years

Influenza

Korea, Republic of
University of Southern California

Recruiting

Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor

Drug Drug Interaction

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

Influenza

United States
National Institute of Allergy and Infectious Diseases...
The Emmes Company, LLC

Completed

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents

Influenza

United States
IRCCS San Raffaele Roma
Agenzia Italiana del Farmaco

Completed

Levodopa Benserazide Generic Formulation Versus the Originator (FARM9X59Y4)

Parkinson Disease

Italy
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Hematologic Disorder

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Cystic Fibrosis

United States, Australia, Canada, Germany, Switzerland, Israel, Netherlands, Belgium, Italy, United Kingdom, France
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation

Cystic Fibrosis

United States, Canada, France, Spain, Israel, Australia, Austria
Ottawa Hospital Research Institute
McMaster University; The Ottawa Hospital; Hamilton Health Sciences Corporation; Sinai Health System

Completed

Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation (PROACTIVE)

Critical Illness | COVID | Sedation | Mechanical Ventilation

Canada
Casa Sollievo della Sofferenza IRCCS
University of Palermo; University of Florence; Campus Bio-Medico University; IRCCS... and other collaborators

Completed

Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE) (WRITE)

Chronic Hepatitis

Italy
Walter J. Storkus
National Cancer Institute (NCI)

Completed

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

Metastatic Melanoma

United States
University of Copenhagen

Completed

Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being (LIFESTAT)

Cardiovascular Disease | Diabetes Mellitus

Denmark
Teva Pharmaceuticals USA

Completed

Anastrozole 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Fondazione Michelangelo

Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 (NeoTRIPaPDL1)

Invasive Ductal Breast Carcinoma

Spain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

Influenza

United States
Pfizer

Completed

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

Influenza

United States
Children's Hospital of Eastern Ontario

Terminated

Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents

Eating Disorder

Canada
Universita degli Studi di Catania

Completed

Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study (TIVAD)

Infections
Mayo Clinic
AstraZeneca

Completed

A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.

Heart Valve Diseases

United States
Hvidovre University Hospital

Completed

Beta-Cell Function After Near-Normalisation of Blood Glucose

Type 2 Diabetes

Denmark
AHS Cancer Control Alberta
Tom Baker Cancer Centre

Recruiting

Pilot Trial for Treatment of Recurrent Glioblastoma

Glioblastoma | Recurrent Glioblastoma | Recurrent Disease

Canada
University of Maryland, Baltimore

Completed

BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients

Epilepsy

United States
National Institute for Tuberculosis and Lung Diseases...

Completed

Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin

Pain, Postoperative | Surgery, Thoracic

Poland
Emory University
National Cancer Institute (NCI); Sanofi; National Institutes of Health (NIH)

Completed

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Plasma Cell Neoplasm

United States
Guyguy K Tshima, MD
Centre Médical de Kinshasa (CMK)

Unknown

COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7 (Tomeka)

Covid19

Congo, The Democratic Republic of the
Zagazig University

Recruiting

Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI

Fertility Issues | Ovary Cyst

Egypt
Baxter Healthcare Corporation

Completed

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Influenza

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)

Influenza

Lithuania
University of California, San Francisco
Flight Attendant Medical Research Institute

Active, not recruiting

Secondhand Smoke Respiratory Health Study

Hyperinflation | Tobacco | Obstructive Lung Disease | Secondhand Smoke | Air Trapping | Airflow Limitation

United States
Children's Hospital Los Angeles
Teva Pharmaceuticals USA

Completed

Albuterol Integrated Adherence Monitoring in Children With Asthma

Asthma in Children

United States
Instituto Oncológico Dr Rosell
Roche Pharma AG; Fundacion Clinic per a la Recerca Biomédica

Active, not recruiting

Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer (VENEZO-LUNG)

Extensive-stage Small Cell Lung Cancer

Spain
Roswell Park Cancer Institute

Completed

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
Tameside Hospital NHS Foundation Trust

Withdrawn

Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus

Endothelial Dysfunction | Bone Disease

United Kingdom
IRCCS San Raffaele

Completed

A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma (PACT-19)

Pancreatic Cancer

Italy
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cardiovascular Inflammation Reduction Trial (CIRT)

Cardiovascular Disease

Canada, United States, Puerto Rico
IRCCS San Raffaele

Completed

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer (PACT-15)

Pancreatic Cancer

Italy
Uppsala University

Recruiting

Efficacy of Hyperthermic Intraperitoneal Chemotherapy (EFFIPEC)

Colorectal Cancer | Peritoneal Metastases

Sweden
MedSIR
Eli Lilly and Company

Active, not recruiting

ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL (ABIGAIL)

Breast Cancer Metastatic

Italy, Spain, Portugal
IRCCS San Raffaele

Terminated

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer (PACT-17)

Pancreatic Cancer

Italy
Sanofi Pasteur, a Sanofi Company

Completed

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

Influenza

United States
Tanta University

Unknown

Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis

Liver Cirrhosis | Muscle Cramps

Egypt
Jules Bordet Institute
Sanofi

Terminated

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Breast Cancer

Belgium
Simon Ducharme, MD
Alzheimer's Drug Discovery Foundation

Active, not recruiting

Nabilone for Agitation in Frontotemporal Dementia (Nabilone-FTD)

Frontotemporal Dementia | Primary Progressive Aphasia | Frontotemporal Dementia, Behavioral Variant | FTD | PPA | bvFTD

Canada
M.D. Anderson Cancer Center

Withdrawn

Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia
Georgios Papadakis

Recruiting

Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome (KLIN-HEALTH)

Klinefelter Syndrome

Switzerland
Jules Bordet Institute
Novartis

Completed

Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women (PEARL)

Breast Cancer

Belgium
Technical University of Munich

Completed

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction (MEMORI)

Adenocarcinoma of the Esophagogastric Junction

Germany
National Institutes of Health Clinical Center (CC)

Completed

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil (GEM-PK)

Healthy Volunteers

United States

Search clinical trials for: TIVA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations